Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Julia E Tubert"'
Autor:
Ana Florea, Lina S Sy, Yi Luo, Lei Qian, Katia J Bruxvoort, Bradley K Ackerson, Gina S Lee, Jennifer H Ku, Julia E Tubert, Yun Tian, Carla A Talarico, Hung Fu Tseng
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267824 (2022)
BackgroundWe conducted a prospective cohort study at Kaiser Permanente Southern California to study the vaccine effectiveness (VE) of mRNA-1273 over time and during the emergence of the Delta variant.MethodsThe cohort for this planned interim analysi
Externí odkaz:
https://doaj.org/article/c446828e016646d9abbf9e3dd70dfc7b
Autor:
Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTEmerging SARS-CoV-2 sublineages continue to cause serious COVID-19 disease, but most individuals have not received any COVID-19 vaccine for >1 year. Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating subli
Externí odkaz:
https://doaj.org/article/2d84f244b16441a592c35ded5e599e4e
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, Julia E. Tubert, Yi Luo, Sijia Qiu, Gina S. Lee, Katia J. Bruxvoort, Jennifer H. Ku, Ana Florea, Harpreet S. Takhar, Radha Bathala, Cindy Ke Zhou, Daina B. Esposito, Morgan A. Marks, Evan J. Anderson, Carla A. Talarico, Lei Qian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized to offer broader protection against COVID-19. We conducted a matched cohort study to evaluate the effectiveness of the bivalent vaccine in preventing hos
Externí odkaz:
https://doaj.org/article/dc26e6eb256c44069443be1e36beb65a
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Sijia Qiu, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna D. Paila, Scott Chavers, Carla A. Talarico, Lei Qian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
In this study, the authors estimate the effectiveness of the mRNA-1273 (Moderna) vaccine for Omicron subvariants using data from the USA on ~31,000 cases and ~92,000 matched controls. They find that effectiveness against infection waned rapidly after
Externí odkaz:
https://doaj.org/article/fc5db9a261e244ce9f8b5ffdd6b33565
Autor:
Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100134- (2022)
Summary: Background: Phase 3 trials found mRNA-1273 was highly effective in preventing COVID-19. We conducted a prospective cohort study at Kaiser Permanente Southern California (KPSC) to determine the real-world vaccine effectiveness (VE) of mRNA-12
Externí odkaz:
https://doaj.org/article/2480a17f26064f04903b9f83ca4b3743
Autor:
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, Gina S Lee, Jennifer H Ku, Katia J Bruxvoort, Carla A Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng
Publikováno v:
Clinical Infectious Diseases. 76:252-262
Background We conducted a prospective cohort study at Kaiser Permanente Southern California to evaluate the relative vaccine effectiveness (rVE) of a booster dose vs 2-dose primary series of messenger RNA (mRNA)-1273 in immunocompetent individuals. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ef2073fcbed46584c350ebe5ac6efa9
https://doi.org/10.1093/cid/ciac785
https://doi.org/10.1093/cid/ciac785
Autor:
Jennifer H. Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia J. Bruxvoort, Carla A. Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng
Publikováno v:
Vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6183b4066306c8ec722520e9d82d713
https://doi.org/10.1016/j.vaccine.2023.04.075
https://doi.org/10.1016/j.vaccine.2023.04.075
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, Lina S. Sy, Carla A. Talarico, Yun Tian, Katia J. Bruxvoort, Julia E. Tubert, Ana Florea, Jennifer H. Ku, Gina S. Lee, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Lei Qian
Publikováno v:
Nature Medicine. 28:1063-1071
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. We conducted a test-negative case–control study to evaluate mRNA-1273 vaccine effectiveness (VE) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e093690e5154aa67c20522bd1732f8
https://doi.org/10.1038/s41591-022-01753-y
https://doi.org/10.1038/s41591-022-01753-y
Autor:
Sara Y. Tartof, Lei Qian, Julia E. Tubert, Michael Aragones, Katia Bruxvoort, Deborah E. Malden, Harpreet S. Takhar, Carla A. Talarico, Hung Fu Tseng, Soon Kyu Choi, Vennis Hong, Ana Florea, John M McLaughlin, Bradley Ackerson
Publikováno v:
Morbidity and Mortality Weekly Report
Data from observational studies demonstrate that variants of SARS-CoV-2, the virus that causes COVID-19, have evolved rapidly across many countries (1,2). The SARS-CoV-2 B.1.617.2 (Delta) variant of concern is more transmissible than previously ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb7b7e47bb2327fdcbaf7a25191f850
https://doi.org/10.15585/mmwr.mm7040a4
https://doi.org/10.15585/mmwr.mm7040a4
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Sijia Qiu, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna D. Paila, Scott Chavers, Carla A. Talarico, Lei Qian
Studies have reported reduced natural SARS-CoV-2 infection- and vaccine-induced neutralization against Omicron BA.4/BA.5 compared with earlier Omicron subvariants. We conducted a test-negative case–control study evaluating mRNA-1273 vaccine effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b23e96ea38821183dcf4f34b008f7a3
https://doi.org/10.1101/2022.09.30.22280573
https://doi.org/10.1101/2022.09.30.22280573
